Andere Kunden interessierten sich auch für
![Probiotics and hepatoprotectors in the treatment of viral hepatitis A and B]( "Probiotics and hepatoprotectors in the treatment of viral hepatitis A and B")
Probiotics and hepatoprotectors in the treatment of viral hepatitis A and B44,99 €![CLINICAL AND THERAPEUTIC ASPECTS OF BREAST CANCER IN HOSPITALS]( "CLINICAL AND THERAPEUTIC ASPECTS OF BREAST CANCER IN HOSPITALS")
CLINICAL AND THERAPEUTIC ASPECTS OF BREAST CANCER IN HOSPITALS26,99 €![Cognitive, Clinical, and Neural Aspects of Drug Addiction]( "Cognitive, Clinical, and Neural Aspects of Drug Addiction")
Cognitive, Clinical, and Neural Aspects of Drug Addiction97,99 €![Epidemiological and therapeutic aspects of tetanus]( "Epidemiological and therapeutic aspects of tetanus")
Epidemiological and therapeutic aspects of tetanus36,99 €![Actinic lichen: anatomoclinical and therapeutic aspects]( "Actinic lichen: anatomoclinical and therapeutic aspects")
Actinic lichen: anatomoclinical and therapeutic aspects26,99 €![Clinical, Radiological and Genetic Investigation of Fahr's Disease]( "Clinical, Radiological and Genetic Investigation of Fahr's Disease")
Clinical, Radiological and Genetic Investigation of Fahr's Disease26,99 €![Epidemiology of viral hepatitis B in the world and in Algeria]( "Epidemiology of viral hepatitis B in the world and in Algeria")
Epidemiology of viral hepatitis B in the world and in Algeria29,99 €
The WHO estimates that 20 million people are infected with the hepatitis E virus every year, making it a worldwide public health problem. Infection with this virus is a clinically under-diagnosed cause of acute and chronic hepatitis. Although progress has been made in understanding the epidemiology, transmission routes, pathophysiological mechanisms, diagnosis and clinical manifestations of hepatitis E, significant gaps remain. There is still a great deal of uncertainty as to the factors influencing the transition from an acute to a chronic form, the long-term prognosis of this form, and the actual efficacy of current therapeutic options. In-depth research is imperative to optimize the prevention and clinical management of this specific form of viral hepatitis, the real impact of which may be vastly underestimated in many contexts.